| Michael Harry Luzecky, MD | |
|
126 Missouri Ave, Mcxp-ccs-cr, Fort Leonard Wood, MO 65473-8952 | |
| (573) 596-0417 | |
| (573) 596-0524 |
| Full Name | Michael Harry Luzecky |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 126 Missouri Ave, Fort Leonard Wood, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174538045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 32413 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Harry Luzecky, MD 126 Missouri Ave, Mcxp-ccs-cr, Fort Leonard Wood, MO 65473-8952 Ph: (573) 596-0417 | Michael Harry Luzecky, MD 126 Missouri Ave, Mcxp-ccs-cr, Fort Leonard Wood, MO 65473-8952 Ph: (573) 596-0417 |
News Archive
The Canadian Epilepsy Alliance is thrilled to announce the launch of a new comic series designed to educate children about the most common neurological disorder in Canada, epilepsy. The Medikidz Explain Epilepsy comic series tells a fictional story based on the experiences of 14-year-old Jack, who is navigating middle school while living with epilepsy.
An escape route mapping system based on the behavior of ant colonies could give evacuees a better chance of reaching safe harbor after a natural disaster or terrorist attack by building a map of showing the shortest routes to shelters and providing regular updates of current situations such as fires, blocked roads or other damage via the smart phones of emergency workers and those caught up in the disaster.
In a development that sheds new light on the pathology of Alzheimer's disease (AD), a team of Whitehead Institute scientists has identified connections between genetic risk factors for the disease and the effects of a peptide toxic to nerve cells in the brains of AD patients.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
› Verified 5 days ago
Dr. Rita R Rein, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave # 1267, Fort Leonard Wood, MO 65473 Phone: 573-596-0522 | |
Dr. Christopher Willis, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4430 Missouri Avenue, Attn: Mcxp-dqs-cr, Fort Leonard Wood, MO 65473 Phone: 573-596-0417 | |
Dr. Jean A Gilstrap, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 126 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0522 Fax: 573-302-4413 |